Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Qiagen (Pecura business)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of veterinary products distribution services. The company's services include holding of veterinary license for the immunstimulatory cytosine-phosphodiester-guanine (CpG) dinucleotides, presented in synthetic oligodeoxynucleotides (CpG-ODN), which are believed to have promising potential in veterinary applications for livestock and companion animals.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Venlo
  • Netherlands

Qiagen (Pecura business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Qiagen (Pecura business)‘s full profile, request access.

Request full access to PitchBook

Qiagen (Pecura business) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Qiagen (Pecura business)‘s full profile, request access.

Request full access to PitchBook

Qiagen (Pecura business) Executive Team (1)

Name Title Board
Seat
Contact
Info
Rolf Hecker Director